Novo Nordisk (DE:NOV)
XETRA:NOV
Want to see DE:NOV full AI Analyst Report?
Total Valuation
Novo Nordisk has a market cap or net worth of €176.36B. The enterprise value is €2.04T.
Market Cap€176.36B
Enterprise Value€2.04T
Share Statistics
Novo Nordisk has 3,390,128,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding3,390,128,000
Owned by Insiders0.01%
Owned by Institutions<0.01%
Financial Efficiency
Novo Nordisk’s return on equity (ROE) is 0.53 and return on invested capital (ROIC) is 29.53%.
Return on Equity (ROE)0.53
Return on Assets (ROA)0.19
Return on Invested Capital (ROIC)29.53%
Return on Capital Employed (ROCE)0.39
Revenue Per Employee3.99M
Profits Per Employee1.32M
Employee Count77,406
Asset Turnover0.57
Inventory Turnover1.18
Valuation Ratios
The current PE Ratio of Novo Nordisk is 5.3. Novo Nordisk’s PEG ratio is ―.
PE Ratio5.3
PS Ratio0.00
PB Ratio0.00
Price to Fair Value7.45
Price to FCF0.00
Price to Operating Cash Flow11.11
PEG Ratio―
Income Statement
In the last 12 months, Novo Nordisk had revenue of 309.06B and earned 102.43B in profits. Earnings per share was 23.06.
Revenue309.06B
Gross Profit250.28B
Operating Income127.66B
Pretax Income130.54B
Net Income102.43B
EBITDA149.44B
Earnings Per Share (EPS)23.06
Cash Flow
In the last 12 months, operating cash flow was 118.59B and capital expenditures -87.57B, giving a free cash flow of 31.03B billion.
Operating Cash Flow118.59B
Free Cash Flow31.03B
Free Cash Flow per Share9.15
Dividends & Yields
Novo Nordisk pays an annual dividend of €0.502, resulting in a dividend yield of 3.47%
Dividend Per Share€0.502
Dividend Yield3.47%
Payout Ratio49.93%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.86
52-Week Price Change-28.33%
50-Day Moving Average33.59
200-Day Moving Average42.57
Relative Strength Index (RSI)64.68
Average Volume (3m)333.55K
Important Dates
Novo Nordisk upcoming earnings date is Aug 6, 2026, Before Open (Confirmed).
Last Earnings DateMay 6, 2026
Next Earnings DateAug 6, 2026
Ex-Dividend Date―
Financial Position
Novo Nordisk as a current ratio of 0.80, with Debt / Equity ratio of 72.09%
Current Ratio0.80
Quick Ratio0.57
Debt to Market Cap0.09
Net Debt to EBITDA0.70
Interest Coverage Ratio18.83
Taxes
In the past 12 months, Novo Nordisk has paid 28.11B in taxes.
Income Tax28.11B
Effective Tax Rate0.22
Enterprise Valuation
Novo Nordisk EV to EBITDA ratio is 10.37, with an EV/FCF ratio of 53.45.
EV to Sales5.01
EV to EBITDA10.37
EV to Free Cash Flow53.45
EV to Operating Cash Flow13.01
Balance Sheet
Novo Nordisk has €21.63B in cash and marketable securities with €118.72B in debt, giving a net cash position of -€124.76B billion.
Cash & Marketable Securities€21.63B
Total Debt€118.72B
Net Cash-€124.76B
Net Cash Per Share-€36.80
Tangible Book Value Per Share€14.40
Margins
Gross margin is 81.85%, with operating margin of 41.30%, and net profit margin of 33.14%.
Gross Margin81.85%
Operating Margin41.30%
Pretax Margin42.24%
Net Profit Margin33.14%
EBITDA Margin48.35%
EBIT Margin43.60%
Analyst Forecast
The average price target for Novo Nordisk is €36.58, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target€36.58
Price Target Upside5.09% Upside
Analyst ConsensusHold
Analyst Count13
Revenue Growth Forecast8.04%
EPS Growth Forecast16.73%